Tag: management board

In connection with the planned completion of the takeover of the shares belonging to minority shareholders in accordance with the resolutions of the general meeting of shareholders held on 26 June 2025 (link to the minutes of the general meeting, in Estonian), the Management Board of Enefit Green submitted today, on 2 July 2025, an application for the delisting of the shares of Enefit Green to the Listing and Supervision Committee of Nasdaq Tallinn.

AB “Ignitis grupė” (hereinafter – the Group) informs that on 30 June, with the agreement of the Group’s Management Board, the Group’s subsidiaries UAB “Ignitis renewables” (hereinafter – Ignitis Renewables) and AB “Ignitis gamyba” (hereinafter – Ignitis Gamyba) made final investment decisions on three battery energy storage system (hereinafter – BESS) projects in Lithuania, with a combined 291 MW power and 582 MWh storage capacity. The German company Rolls-Royce Solutions GmbH will provide the equipment and the integration services for all three BESS projects.

AB “Ignitis grupė” (hereinafter – the Group) informs that on 30 June, with the agreement of the Group’s Management Board, the Group’s subsidiaries UAB “Ignitis renewables” (hereinafter – Ignitis Renewables) and AB “Ignitis gamyba” (hereinafter – Ignitis Gamyba) made final investment decisions on three battery energy storage system (hereinafter – BESS) projects in Lithuania, with a combined 291 MW power and 582 MWh storage capacity. The German company Rolls-Royce Solutions GmbH will provide the equipment and the integration services for all three BESS projects.

WARSAW, Poland, June 26, 2025 (GLOBE NEWSWIRE) -- BNPL payments are no longer just a way of financing purchases, but also constitute an innovative factor supporting the development of the Polish credit market. An analysis carried out by the Polish credit bureau BIK found that BNPL users are good at repaying their debts. For 40 percent of “thin-file bank customers” who also use BNPL, combining the two data sources may improve their creditworthiness. The degree of such an improvement can have a significant impact on credit decisions. It is also worth noting that this analysis was made possible by the unique data gathered by BIK and by the reporting standards for BNPL transactions developed together with the financial sector.

Press release

The annual general meeting of shareholders of AS Trigon Property Development (registry code: 10106774; hereinafter the “Company”) was held on 20 June 2025 in Tallinn, Pärnu mnt 18.

Mr Priit Rohumaa’s term as a member of the Supervisory Board of Admirals Group AS ended on 17 June 2025. Admirals Group AS extends its sincere gratitude to Mr Rohumaa for his valuable contributions and dedication during his tenure.

Aix-en-Provence, 17 June 2025 (8.00 a.m.)

The management board of Hepsor AS, registry code 12099216 (hereinafter the Company) published on 5 June 2025 pursuant to § 299¹ subsections 1, 2 and 3 of the Commercial Code the draft resolutions for the adoption of shareholders’ resolutions without calling a meeting.

On 5 June 2025, the Annual General Meeting of Arco Vara AS adopted the decision to issue a targeted share offering to specific investors in order to increase the company’s share capital.
Arco Vara AS announces that the targeted share issue approved by the shareholders has been successfully completed as of 11 June 2025 – the management board has adopted a resolution to shorten the subscription period due to early subscription of issued shares. In accordance with the adopted decision of the general meeting:

WOBURN, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company focused on the development and commercialization of photodynamic therapy (PDT), confirms a disclosure by the Management Board of Biofrontera AG on June 10, 2025, according to which the two companies are in negotiations regarding a possible combination of the two companies or an adjustment of the license and supply agreement between them. The latter could result in the transfer of certain rights and obligations from Biofrontera AG to Biofrontera Inc. and a reduction in the transfer price for Biofrontera Inc.’s licensed products sold in the US.